The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital

被引：0
|
作者：
Whiteoak, S. [1 ]
Johnson, H. [1 ]
Hovell, C. [1 ]
Weaver, S. [1 ]
McLaughlin, S. [1 ]
机构：
[1] Royal Bournemouth Hosp, Dept Gastroenterol, Bournemouth, Dorset, England
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P645
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 40 条
  • [31] Therapeutic drug monitoring of vancomycin in neurosurgery patients, from trough concentration to area under the curve: a retrospective single center cohort study in a tertiary hospital
    Chen, Yue
    Kong, Xudong
    Liu, Lei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (03)
  • [32] An analysis of cost savings achieved through the practice of vial sharing for patients receiving bortezomib (Velcade®) containing regime in multiple myeloma in a district general hospital (DGH) haematology unit over a two year period
    Bartlett, M.
    Hughes, J.
    Grubb, H.
    Kundu, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 83 - 84
  • [33] THERAPEUTIC DRUG MONITORING (TDM) OF INFLIXIMAB IS ASSOCIATED WITH LOWER BIOLOGIC SWITCH & EXPENDITURES COMPARED TO NO-TDM COHORT OF IBD PATIENTS BASED ON 12 TO 48-MONTH REAL-WORLD OUTCOMES FROM A US COMMUNITY GI PRACTICE
    Shim, A.
    Young, K.
    Sabban, A.
    Eisdorfer, R.
    Rosenberg, S.
    VALUE IN HEALTH, 2024, 27 (06) : S389 - S389
  • [34] Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
    Perrone, Valentina
    Cattaneo, Dario
    Radice, Sonia
    Sangiorgi, Diego
    Federici, Augusto B.
    Gismondo, Maria Rita
    Medaglia, Massimo
    Micheli, Valeria
    Vimercati, Stefania
    Pallone, Enza
    Esposti, Luca Degli
    Clementi, Emilio
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 341 - 348
  • [35] Therapeutic Drug Monitoring of 6 New-Generation Antiseizure Medications Using a Mass Spectrometry Method Analysis of 2-Year Experience in a Large Cohort of Korean Epilepsy Patients
    Kim, Sang-Mi
    Heo, Won Young
    Oh, Hyeonju
    Joo, Eun Yeon
    Shon, Young-Min
    Hong, Seung Bong
    Lee, Soo-Youn
    Seo, Dae-Won
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2025, 149 (01) : 67 - 74
  • [36] A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs-monitoring of therapeutic drug efficacy as a case study
    Coffeng, Luc
    Vlaminck, Johnny
    Cools, Piet
    Denwood, Matthew J.
    Albonico, Marco
    Ame, Shaali
    Ayana, Mio
    Dana, Daniel
    Cringoli, Giuseppe
    de Vlas, Sake
    Fenwick, Alan F.
    French, Michael P.
    Kazienga, Adama
    Keiser, Jennifer
    Knopp, Stefanie
    Leta, Gemechu
    Matoso, Leonardo A.
    Maurelli, Maria
    Montresor, Antonio
    Mirams, Greg
    Mekonnen, Zeleke
    Correa-Oliveira, Rodrigo
    Pinto, Simone
    Rinaldi, Laura
    Sayasone, Somphou
    Steinmann, Peter
    Thomas, Eurion
    Vercruysse, Jozef
    Levecke, Bruno
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (05):
  • [37] COMPARING REAL-WORLD OUTCOMES, MEASURED AS 12 AND 24-MONTH IBD-RELATED SURGERIES, BETWEEN INFLIXIMAB DOSE OPTIMIZED PATIENTS USING THERAPEUTIC DRUG MONITORING (TDM) VS AN UNOPTIMIZED CONTROL GROUP, IN A LARGE US COMMUNITY-BASED GASTROENTEROLOGY PRACTICES
    Shim, Andrew
    Han, Patita
    Young, Kendra
    St Jacque, Samantha
    Sabban, Amit
    Eisdorfer, Robert
    Rosenberg, Shahar
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S83 - S84
  • [38] COMPARING REAL-WORLD OUTCOMES, MEASURED AS 12 AND 24-MONTH IBD-RELATED SURGERIES, BETWEEN INFLIXIMAB DOSE OPTIMIZED PATIENTS USING THERAPEUTIC DRUG MONITORING (TDM) VS AN UNOPTIMIZED CONTROL GROUP, IN A LARGE US COMMUNITY-BASED GASTROENTEROLOGY PRACTICES
    Shim, Andrew
    Han, Patita
    Young, Kendra
    St Jacque, Samantha
    Sabban, Amit
    Eisdorfer, Robert
    Rosenberg, Shahar
    GASTROENTEROLOGY, 2024, 166 (03) : S116 - S116
  • [39] An analysis of the cost savings achieved through practice of vial sharing for patients on azacitidine (Vidaza®) treatment for myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML with 10-29% blasts) and acute myeloid leukaemia (AML with 20-30% blasts) in a district general hospital (DGH) haematology unit over a 2 years period
    Bartlett, M.
    Thomas, T.
    Hughes, J.
    Grubb, H.
    Kundu, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 123 - 124
  • [40] Therapeutic drug monitoring during cyclosporine A (CsA) tapering in patients with severe/very severe aplastic anemia (s/vsAA): real-life data suggesting a CsA plasma level above 100 ng/mL associated with low risk of AA relapse
    Walter, J.
    Kricheldorf, K.
    Schiffers, J.
    Schumacher, Y.
    Isfort, S.
    Chromik, J.
    Panse, J.
    Bruemmendorf, T. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 44 - 45
1234